Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Seth J. Zost, … , Andrew B. Ward, James E. Crowe Jr.
Seth J. Zost, … , Andrew B. Ward, James E. Crowe Jr.
Published June 22, 2021
Citation Information: J Clin Invest. 2021;131(15):e146791. https://doi.org/10.1172/JCI146791.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 10

Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

  • Text
  • PDF
Abstract

Broadly reactive antibodies targeting the influenza A virus hemagglutinin (HA) head domain are thought to be rare and to require extensive somatic mutations or unusual structural features to achieve breadth against divergent HA subtypes. Here we describe common genetic and structural features of protective human antibodies from several individuals recognizing the trimer interface (TI) of the influenza A HA head, a recently identified site of vulnerability. We examined the sequence of TI-reactive antibodies, determined crystal structures for TI antibody–antigen complexes, and analyzed the contact residues of the antibodies on HA to discover common genetic and structural features of TI antibodies. Our data reveal that many TI antibodies are encoded by a light chain variable gene segment incorporating a shared somatic mutation. In addition, these antibodies have a shared acidic residue in the heavy chain despite originating from diverse heavy chain variable gene segments. These studies show that the TI region of influenza A HA is a major antigenic site with conserved structural features that are recognized by a common human B cell public clonotype. The canonical nature of this antibody–antigen interaction suggests that the TI epitope might serve as an important target for structure-based vaccine design.

Authors

Seth J. Zost, Jinhui Dong, Iuliia M. Gilchuk, Pavlo Gilchuk, Natalie J. Thornburg, Sandhya Bangaru, Nurgun Kose, Jessica A. Finn, Robin Bombardi, Cinque Soto, Elaine C. Chen, Rachel S. Nargi, Rachel E. Sutton, Ryan P. Irving, Naveenchandra Suryadevara, Jonna B. Westover, Robert H. Carnahan, Hannah L. Turner, Sheng Li, Andrew B. Ward, James E. Crowe Jr.

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 2 5 7 7 2 1 24
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (24)

Title and authors Publication Year
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins
Guthmiller JJ, Lan LY, Li L, Fu Y, Nelson SA, Henry C, Stamper CT, Utset HA, Freyn AW, Han J, Stovicek O, Wang J, Zheng NY, Huang M, Dugan HL, Tepora ME, Zhu X, Chen YQ, Palm AK, Shaw DG, Loganathan M, Francis BF, Sun J, Chervin J, Troxell C, Meade P, Leung NH, Valkenburg SA, Cobey S, Cowling BJ, Wilson IA, García-Sastre A, Nachbagauer R, Ward AB, Coughlan L, Krammer F, Wilson PC
Immunity 2025
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface
Simmons HC, Finney J, Kotaki R, Adachi Y, Moseman AP, Watanabe A, Song S, Robinson-McCarthy LR, Le Sage V, Kuraoka M, Moseman EA, Kelsoe G, Takahashi Y, McCarthy KR
mBio 2025
Potent HPIV3-neutralizing IGHV5–51 antibodies identified from multiple individuals show light chain and CDRH3 promiscuity: HPIV3-neutralizing mAbs show light chain & CDRH3 promiscuity
Abu-Shmais AA, Miller RJ, Janke AK, Wolters RM, Holt CM, Raju N, Carnahan RH, Crowe JE Jr, Mousa JJ, Georgiev IS
Journal of immunology (Baltimore, Md. : 1950) 2024
Immune memory shapes human polyclonal antibody responses to H2N2 vaccination
Yang YR, Han J, Perrett HR, Richey ST, Rodriguez AJ, Jackson AM, Gillespie RA, O\u2019Connell S, Raab JE, Cominsky LY, Chopde A, Kanekiyo M, Houser KV, Chen GL, McDermott AB, Andrews SF, Ward AB
Cell Reports 2024
Antibody sequence determinants of viral antigen specificity
Abu-Shmais AA, Vukovich MJ, Wasdin PT, Suresh YP, Marinov TM, Rush SA, Gillespie RA, Sankhala RS, Choe M, Joyce MG, Kanekiyo M, McLellan JS, Georgiev IS
mBio 2024
Modulation of B cell receptor activation by antibody competition
He Y, Guo Z, Vahey MD
bioRxiv 2024
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen
Verhoeven D, Sponseller BA, Crowe JE Jr, Bangaru S, Webby RJ, Lee BM
NPJ Vaccines 2024
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Ellis D, Dosey A, Boyoglu-Barnum S, Park YJ, Gillespie R, Syeda H, Tsybovsky Y, Murphy M, Pettie D, Matheson N, Chan S, Ueda G, Fallas JA, Carter L, Graham BS, Veesler D, Kanekiyo M, King NP
2023
Increasing sensitivity of antibody-antigen interactions using photo-cross-linking
Torrents de la Peña A, Sewall LM, de Paiva Froes Rocha R, Jackson AM, Pratap PP, Bangaru S, Cottrell CA, Mohanty S, Shaw AC, Ward AB
2023
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
Tonouchi K, Adachi Y, Suzuki T, Kuroda D, Nishiyama A, Yumoto K, Takeyama H, Suzuki T, Hashiguchi T, Takahashi Y
PLoS pathogens 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
Chen EC, Gilchuk P, Zost SJ, Ilinykh PA, Binshtein E, Huang K, Myers L, Bonissone S, Day S, Kona CR, Trivette A, Reidy JX, Sutton RE, Gainza C, Diaz S, Williams JK, Selverian CN, Davidson E, Saphire EO, Doranz BJ, Castellana N, Bukreyev A, Carnahan RH, Crowe JE Jr
Cell Reports 2023
Immune memory shapes human polyclonal antibody responses to H2N2 vaccination
Yang YR, Han J, Perrett HR, Richey ST, Jackson AM, Rodriguez AJ, Gillespie RA, O\u2019Connell S, Raab JE, Cominsky LY, Chopde A, Kanekiyo M, Houser KV, Chen GL, McDermott AB, Andrews SF, Ward AB
2023
A broad antibody class engages the influenza virus hemagglutinin head at its stem interface
Simmons HC, Finney J, Kotaki R, Adachi Y, Moseman AP, Watanabe A, Song S, Robinson-McCarthy LR, Sage VL, Kuraoka M, Moseman EA, Kelsoe G, Takahashi Y, McCarthy KR
2023
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Ellis D, Dosey A, Boyoglu-Barnum S, Park YJ, Gillespie R, Syeda H, Hutchinson GB, Tsybovsky Y, Murphy M, Pettie D, Matheson N, Chan S, Ueda G, Fallas JA, Carter L, Graham BS, Veesler D, Kanekiyo M, King NP
Cell Reports 2023
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
Naveenchandra Suryadevara, Andrea R Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E Chen, James Brett Case, Kevin J Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin Doranz, Summer Diaz, Laura S Handal, Robert H Carnahan, Michael Diamond, Ivelin Georgiev, James E. Crowe Jr.
Journal of Clinical Investigation 2022
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited by a chimeric hemagglutinin-based universal influenza virus vaccine
Teresa Aydillo, Ana Gonzalez-Reiche, Daniel Stadlbauer, Mary Amper, Venugopalan Nair, Chiara Mariottini, Stuart Sealfon, Harm Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
npj Vaccines 2022
Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
C Murin, P Gilchuk, J Crowe, A Ward
Frontiers in immunology 2022
Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions
F Milder, M Jongeneelen, T Ritschel, P Bouchier, I Bisschop, M de Man, D Veldman, L Le, B Kaufmann, M Bakkers, J Juraszek, B Brandenburg, J Langedijk
Proceedings of the National Academy of Sciences 2022
Breathing and tilting: mesoscale simulations illuminate influenza glycoprotein vulnerabilities
Casalino L, Seitz C, Lederhofer J, Tsybovsky Y, Wilson IA, Kanekiyo M, Amaro RE
2022
Identification and analysis of B cell epitopes of hemagglutinin of H1N1 influenza virus
Feng Q, Huang XY, Feng YM, Sun LJ, Sun JY, Li Y, Xie X, Hu J, Guo CY
Archives of Microbiology 2022
Breathing and Tilting: Mesoscale Simulations Illuminate Influenza Glycoprotein Vulnerabilities
Casalino L, Seitz C, Lederhofer J, Tsybovsky Y, Wilson IA, Kanekiyo M, Amaro RE
ACS Central Science 2022
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
EC Chen, P Gilchuk, SJ Zost, N Suryadevara, ES Winkler, CR Cabel, E Binshtein, RE Chen, RE Sutton, J Rodriguez, S Day, L Myers, A Trivette, JK Williams, E Davidson, S Li, BJ Doranz, SK Campos, RH Carnahan, CA Thorne, MS Diamond, JE Crowe
Cell Reports 2021
In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies
S Pagant, RA Liberatore
Pharmaceutics 2021
Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface
Jinhui Dong, Iuliia Gilchuk, Sheng Li, Ryan Irving, Matt Goff, Hannah L. Turner, Andrew B. Ward, Robert H Carnahan, James E. Crowe Jr.
Journal of Clinical Investigation 2020

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 16 X users
36 readers on Mendeley
See more details